Over the past 12‑18 months the 1,1-Dichloroacetone (1,1-DCA) market has shown a surge of strategic activity that is reshaping supply dynamics and end‑user applications. In Q2 2024, ChemCo International entered a long‑term partnership with GreenSynth Labs to co‑develop a greener synthesis route that reduces halogen waste by 30 %. Meanwhile, European specialty chemicals group Solvay completed the acquisition of US‑based Aldrich Chemicals, adding a proprietary 1,1‑DCA purification platform to its portfolio. Early 2024 also saw the launch of a high‑purity, low‑odor 1,1‑DCA grade by Sigma‑Aldrich, targeting pharmaceutical intermediates and enabling faster API development cycles. Regulatory pressure intensified when the EU revised REACH guidelines in November 2023, classifying 1,1‑DCA as a substance of very high concern, prompting manufacturers to invest in closed‑loop processing. On the demand side, the rise of bio‑based polymer manufacturers in Asia has increased bulk consumption, while a $45 million Series B funding round for biotech startup NovaChem accelerated its scale‑up of 1,1‑DCA‑derived cross‑linkers. These moves collectively illustrate the evolving 1,1-Dichloroacetone (1,1-DCA) industry trends and set the stage for continued consolidation and innovation.